Our results showed that the decreased expression of miR-124 may be associated with malignant tumor progression and poor prognosis in patients with gliomas,suggesting that miR-124 may be a novel and valuable signature for predicting the clinical outcome of patients with gliomas.
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback